Skip to main content

Cipla 422 100 mg Pill - white capsule/oblong, 18mm

Pill with imprint Cipla 422 100 mg is White, Capsule/Oblong and has been identified as Celecoxib 100 mg. It is supplied by Cipla USA Inc.

Celecoxib is used in the treatment of Ankylosing Spondylitis; Osteoarthritis; Chronic Pain; Familial Adenomatous Polyposis; Juvenile Rheumatoid Arthritis and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 422 100 mg

Celecoxib 100 mg Cipla 422 100 mg
Celecoxib 100 mg Cipla 422 100 mg

Celecoxib

Imprint
Cipla 422 100 mg
Strength
100 mg
Color
White
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0422
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone, sodium lauryl sulfate, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.